Authors/Disclosures
|
Robert Zivadinov, MD, PhD, FAAN
(Buffalo Neuroimaging Analysis Center)
|
The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. |
|
Michael G. Dwyer III, MD, PhD
(Buffalo Neurological Analysis Center)
|
Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche. |
|
Niels Bergsland
(Buffalo Neuroimaging Analysis Center / State University of New York At Buffalo)
|
Prof. Bergsland has nothing to disclose. |
|
|
No disclosure on file |
|
Jackie Durfee
(JNI - BNAC)
|
No disclosure on file |
|
|
No disclosure on file |
|
David Miller
|
No disclosure on file |
|
|
No disclosure on file |
|
Laura Willis, BA
|
No disclosure on file |
|
Jennifer L. Cox, PhD
|
Dr. Cox has nothing to disclose. |
|
|
No disclosure on file |
|
Carmen Castrillo-Viguera
|
Dr. Castrillo-Viguera has received personal compensation for serving as an employee of Biogen. Dr. Castrillo-Viguera has received stock or an ownership interest from Biogen. |
|
David H. Margolin, MD, PhD
(Genzyme Corporation)
|
Dr. Margolin has received personal compensation for serving as an employee of uniQure, Inc.. Dr. Margolin has stock in Cerevance, Inc. Dr. Margolin has stock in Datacubed Health. Dr. Margolin has stock in uniQure, Inc.. Dr. Margolin has received intellectual property interests from a discovery or technology relating to health care. |
|
Marco A. Rizzo, MD, PhD
|
No disclosure on file |
|
|
No disclosure on file |